New Delhi, 20 November
The Union Health Ministry has notified the inclusion of coronary stents in the National List of Essential Medicines, 2022, a move that will help make these life-saving medical devices more affordable.
The move was taken on the recommendation of an expert committee constituted to review the inclusion of stents in the list based on necessity.
The National Pharmaceutical Pricing Authority (NPPA) will now set the price of coronary stents.
On November 6, the Standing National Committee on Medicines (SNCM) submitted its recommendation to include coronary stents in two categories in the National List of Essential Medicines (NLEM), 2022 – bare metal stents (BMS) and drug eluting stents (DES) whose These include metallic DES and bioresorbable vascular scaffold (VBS)/biodegradable stents.
According to SNCM meeting minutes, Vice Chairman Dr YK Gupta said coronary stents were earlier included in NLEM, 2015 through a separate notification based on the recommendation of an expert committee.
“As far as medicine is concerned, SNCM has already submitted its report on NLEM, 2022 and it has been accepted by the government,” an official source said.
SNCM discussed the essentiality, classification and other relevant aspects of coronary stents.
It also states that coronary artery disease (CAD) is a public health problem associated with high morbidity and mortality. There is a great need for percutaneous coronary interventions that require coronary stent implantation.
Therefore, coronary stents should continue to be essential medical devices, committee members agreed.
“After considering all aspects of coronary stent, the committee has recommended that coronary stent is an essential medical device notified as a ‘drug’ under the Drugs and Cosmetics Act, 1940 and hence should be included in the NLEM, 2022,” an official said. .
In case of coronary stents, the authorities should consider different coronary stents separately under the category of bare metal stents and drug eluting stents for the purpose of NLEM, he said.
The Indian Council of Medical Research and other relevant institutions may also consider taking necessary initiatives to generate data for post-marketing safety and efficacy evaluation of coronary stents used in various hospitals/institutions, the members said.
“Following the recommendations of the expert committee, the Union Health Ministry has notified the inclusion of coronary stents in the National List of Essential Medicines (NLEM), 2022,” the official added.
Among the 34 new additions to the National List of Essential Medicines released on September 13 were several anti-cancer drugs, antibiotics and vaccines, taking the total number of drugs under it to 384.